CTVS

MARCH 31, 2025

An estimated 700,000 sternotomies are performed annually in the United States. It is a serious surgery that opens up the chest cavity through the breastbone, or sternum, to gain access to the lungs and heart.

Innovation 52

Innovation Technology Aortic valve Aortic 52

Society of Thoracic Surgeons - Technology

MARCH 2, 2022

Blog Introducing New Technology to an Institution jbagley Wed, 03/02/2022 - 11:15 Innovation and new technology are essential to the progress of any specialty. Emerging technologies remain a staple of the specialty and early career surgeons play an important role in the process. Image Robert M.

Technology 52

Technology Blog Cardiothoracic Outcomes 52

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

The linkage also would allow registries to continue providing critical information for approval and coverage of innovative medical interventions and preserve the government’s authority to authorize Medicare Coverage with Evidence Development (CED). Learn more at sts.org. For more, visit acc.org.

Technology 40

Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve 40

Society of Thoracic Surgeons - Technology

JANUARY 19, 2022

This fellowship also will allow Dr. Fiedler and Dr. Folesani to learn novel techniques, adapt innovative technology, and receive training from expert mentors who are dedicated to the highest standards of cardiothoracic surgery. She will study under Stephen Large, MD, MA, FRCS, at Royal Papworth Hospital in Cambridge, England.

Cardiothoracic 52

Cardiothoracic Heart Transplant Allied Health Education 52

Society of Thoracic Surgeons - Technology

JANUARY 18, 2021

The authors share some of the exciting and innovative features planned for STS 2021—which are expected to be unlike anything the cardiothoracic surgery specialty has seen to date. gtrainyte Mon, 01/18/2021 - 08:13 Duration 36 min Beyond the Abstract Career Development Technology Image

Best Practices 52

Best Practices Cardiothoracic Article Academic 52

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

Society of Thoracic Surgeons - Research

FEBRUARY 5, 2024

Preserve Medical Research Funding gtrainyte Mon, 02/05/2024 - 10:50 Scroll to top Preserve Medical Research Funding Supporting investments into research funding that enables surgeons to explore innovative techniques, cutting-edge technologies, and novel therapies that can revolutionize the diagnosis and treatment of thoracic diseases.

Research 40

Research Cancer Cardiothoracic Innovation 40